Access practical guides, ROI calculators, and success stories designed to help you benchmark and improve your revenue cycle.
HealthCell handles billing for infusion therapy (biologics and small molecules), joint injections, bone density testing, chronic disease management, and E/M visits for conditions including RA, lupus, psoriatic arthritis, and gout. We are trained on rheumatology-specific drug and infusion codes. We also manage billing for musculoskeletal ultrasound guidance increasingly used in rheumatology practices for joint and soft tissue injections.
Biologic infusions require accurate HCPCS J-codes, correct administration sequencing, and prior authorizations that must be maintained over time. HealthCell manages the entire process—from pre-auth to post-infusion billing—to ensure your practice captures the full value of every infusion visit. We also conduct drug cost versus reimbursement analysis to help rheumatology practices evaluate the financial performance of their infusion programs.
Yes. We manage prior authorizations for drugs including adalimumab, rituximab, abatacept, and other biologics. Our team tracks approval timelines, handles appeals for denied requests, and ensures continuity of authorization to prevent billing gaps. We also manage step therapy appeals when payers require trials of less expensive therapies before approving the prescribed biologic regimen.
Rheumatology denials are frequently tied to medical necessity documentation, step therapy requirements for biologics, and infusion coding errors. HealthCell’s billers are trained on these denial patterns and apply prevention protocols specific to rheumatology practices. Our team also monitors payer policy updates for biologic coverage criteria, which change frequently and significantly affect rheumatology revenue.
Rheumatology involves high-cost biologic therapies, complex infusion coding, frequent step therapy mandates, and long-term chronic disease management. HealthCell’s specialized team navigates these challenges to ensure accurate reimbursement and sustainable revenue for your practice. We also support rheumatology practices participating in treat-to-target and outcomes-based contracts that require distinct documentation and reporting workflows.
The trusted financial backbone for independent practices—stable collections, fewer denials, and freedom to focus on care.
